The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/36381
StudyName: Eligibility Metastatic Breast Cancer NCT02263495
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 08.05.2019
License: Creative Commons BY 4.0

----

Description: 
Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02263495
